EOFLOW to launch insulin patch in Europe next month, shares uplifted

Pulse 2022. 8. 11. 13:57
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

닫기

[Source: EOFLOW]

[Source: EOFLOW]
EOFLOW shares were uplifted by 3.47 percent to trade at 20,900 won ($16.05) Thursday afternoon as the Korean developer of a wearable insulin delivery system is poised to launch its insulin patch across Europe next month.

The company’s European partner Menarini is responsible for local distribution under a five-year contract worth 150 billion won signed in 2019.

Insulin patches, an experimental form of insulin delivery, aim to painlessly deliver insulin through the skin.

Menarini has been preparing for launch by completing product registration in 10 European countries, including Italy, Britain, Spain and Germany. The product will be sold under the brand name of GlucoMen Day PUMP from September 1.

[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]

Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지

이 기사에 대해 어떻게 생각하시나요?
매일경제에서 직접 확인하세요. 해당 언론사로 이동합니다.